HIV-1 protease inhibitor induced oxidative stress suppresses glucose stimulated insulin release: protection with thymoquinone (Q39881130)

15 September 2017

HIV-1 protease inhibitor induced oxidative stress suppresses glucose stimulated insulin release: protection with thymoquinone (English)

1 reference

15 September 2017

0 references

0 references

1 reference

Surabhi Chandra

1

1 reference

15 September 2017

Debasis Mondal

series ordinal

2

1 reference

15 September 2017

Krishna C Agrawal

series ordinal

3

1 reference

15 September 2017

language of work or name

1 reference

20 February 2009

1 reference

Experimental Biology and Medicine

15 September 2017

1 reference

15 September 2017

234

1 reference

15 September 2017

4

1 reference

15 September 2017

442-453

1 reference

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

15 September 2017

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-317

Highly active antiretroviral therapy (HAART) for the treatment of infection with human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-317

The long-term effects of anti-retroviral protease inhibitors on sugar transport in L6 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-317

Long-term effects of HIV-1 protease inhibitors on insulin secretion and insulin signaling in INS-1 beta cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-317

Mechanisms for the deterioration in glucose tolerance associated with HIV protease inhibitor regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-317

HIV protease inhibitors acutely impair glucose-stimulated insulin release.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-317

HAART drugs induce oxidative stress in human endothelial cells and increase endothelial recruitment of mononuclear cells: exacerbation by inflammatory cytokines and amelioration by antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-317

Nelfinavir induces necrosis of 3T3F44-2A adipocytes by oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-317

Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-317

Reactive oxygen species as a signal in glucose-stimulated insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-317

Superoxide-mediated activation of uncoupling protein 2 causes pancreatic beta cell dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-317

Uncoupling proteins: their roles in adaptive thermogenesis and substrate metabolism reconsidered

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-317

A radical explanation for glucose-induced beta cell dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-317

Mitochondrial dysfunction and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-317

Lack of effect of oral vitamin C on blood pressure, oxidative stress and endothelial function in Type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-317

Thymoquinone suppresses expression of inducible nitric oxide synthase in rat macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-317

The influence of thymoquinone on doxorubicin-induced hyperlipidemic nephropathy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-317

The hypoglycemic effect of Nigella sativa oil is mediated by extrapancreatic actions

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-317

Successful abrogation by thymoquinone against induction of diabetes mellitus with streptozotocin via nitric oxide inhibitory mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-317

Nigella sativa oil, nigellone and derived thymoquinone inhibit synthesis of 5-lipoxygenase products in polymorphonuclear leukocytes from rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-317

Crystal structure determination of thymoquinone by high-resolution X-ray powder diffraction

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-317

Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-317

Indinavir impairs endothelial function in healthy HIV-negative men

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-317

Long-term body composition and metabolic changes in antiretroviral naive persons randomized to protease inhibitor-, nonnucleoside reverse transcriptase inhibitor-, or protease inhibitor plus nonnucleoside reverse transcriptase inhibitor-based strate

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-317

Direct interference of HIV protease inhibitors with pancreatic beta-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-317

Indinavir induces acute and reversible peripheral insulin resistance in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-317

Cardiovascular risk in patients with HIV Infection: impact of antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-317

Cardiovascular risk score change in HIV-1-infected patients switched to an atazanavir-based combination antiretroviral regimen.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-317

Clinical significance, pathogenesis, and management of postprandial hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-317

Targeting postprandial hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-317

Insulin Resistance and Diabetes Mellitus in HIV-Infected Patients Receiving Antiretroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-317

HIV-protease inhibitors induce expression of suppressor of cytokine signaling-1 in insulin-sensitive tissues and promote insulin resistance and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-317

Protease inhibitor-induced diabetic complications : incidence, management and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-317

HIV-associated lipodystrophy: a review of underlying mechanisms and therapeutic options

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-317

Metabolic effects of rosiglitazone in HIV lipodystrophy: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-317

Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-317

S-nitrosothiols signal hypoxia-mimetic vascular pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-317

Curcumin blocks HIV protease inhibitor ritonavir-induced vascular dysfunction in porcine coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-317

Ginsenoside Rb1 blocks homocysteine-induced endothelial dysfunction in porcine coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-317

Alpha-lipoic acid supplementation and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-317

Protease inhibitors and cardiovascular outcomes in patients with HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-317

21 January 2018

Identifiers

DOI

10.3181/0811-RM-317

1 reference

15 September 2017

1 reference